Directa Plus (GB:DCTA) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Directa Plus, a key player in graphene nanoplatelet-based products, is launching a fundraising initiative aimed at generating between £6.8 million and £6.9 million to capitalize on significant growth opportunities. The fundraising includes a conditional placing and subscription, which will see the issue of over 38 million new shares, with Nant Capital LLC, the company’s largest shareholder, expressing substantial interest. The success of this fundraising, which is subject to shareholder approval, could mark a new phase of accelerated growth for the company.
For further insights into GB:DCTA stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue